Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
16 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/16/2946376/0/en/PatientSeek-identifies-a-genetic-signature-that-separates-a4b7-integrin-therapy-responder-and-non-responder-populations-in-inflammatory-bowel-disease.html
22 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/22/2916293/0/en/C4X-Discovery-Holdings-Limited-announces-progress-on-immuno-inflammation-programmes-and-appointment-of-new-Board-members.html
01 Aug 2023
// ACCESSWIRE
01 Aug 2023
// James Waldron FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/c4x-sells-full-rights-substance-disorder-drug-indivior-part-inflammation-refocus
22 Feb 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/02/22/2612849/0/en/C4XD-and-Garvan-Institute-of-Medical-Research-report-successful-patient-stratification-approach-using-C4XD-s-new-precision-medicine-platform-PatientSeek.html
29 Nov 2022
// PHARMACEUTICAL-TECHNOLOGY
https://www.pharmaceutical-technology.com/news/c4xd-astrazeneca-deal-respiratory-disease/
ABOUT THIS PAGE